Cargando…

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest

Cholangiocarcinoma (CCA) is at an advanced stage at the time of its diagnosis, and developing a more effective treatment of CCA would be desirable. Angiotensin II type 1 (AT1) receptor blocker (ARB), telmisartan may inhibit cancer cell proliferation, but the mechanisms by which telmisartan affects v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samukawa, Eri, Fujihara, Shintaro, Oura, Kyoko, Iwama, Hisakazu, Yamana, Yoshimi, Tadokoro, Tomoko, Chiyo, Taiga, Kobayashi, Kiyoyuki, Morishita, Asahiro, Nakahara, Mai, Kobara, Hideki, Mori, Hirohito, Okano, Keiichi, Suzuki, Yasuyuki, Himoto, Takashi, Masaki, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673010/ https://www.ncbi.nlm.nih.gov/pubmed/29075786 http://dx.doi.org/10.3892/ijo.2017.4177

Ejemplares similares

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
por: Oura, Kyoko, et al.
Publicado: (2017)

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKa/mTOR pathway in vitro and in vivo
por: Fujihara, Shintaro, et al.
Publicado: (2016)

Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
por: Matsui, Takanori, et al.
Publicado: (2019)

Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
por: Nakahara, Mai, et al.
Publicado: (2022)

Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
por: Morishita, Asahiro, et al.
Publicado: (2021)

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
por: Takuma, Kei, et al.
Publicado: (2022)

Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017)

Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
por: Chiyo, Taiga, et al.
Publicado: (2019)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

Differences in miRNA expression profiles between GIST and leiomyoma in human samples acquired by submucosal tunneling biopsy
por: Fujita, Koji, et al.
Publicado: (2015)

Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis
por: Shi, Tingting, et al.
Publicado: (2020)

Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
por: Kohno, Tomoki, et al.
Publicado: (2020)

Association between microRNA-527 and glypican-3 in hepatocellular carcinoma
por: Nomura, Kei, et al.
Publicado: (2021)

MicroRNA profiles in various hepatocellular carcinoma cell lines
por: Morishita, Asahiro, et al.
Publicado: (2016)

Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients
por: Fujita, Koji, et al.
Publicado: (2018)

MicroRNAs and Nonalcoholic Steatohepatitis: A Review
por: Morishita, Asahiro, et al.
Publicado: (2023)

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up
por: Tadokoro, Tomoko, et al.
Publicado: (2021)

Albumin–Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study
por: Fujita, Koji, et al.
Publicado: (2019)

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir
por: Morishita, Asahiro, et al.
Publicado: (2018)

MicroRNA profile of hepatic epithelioid hemangioendothelioma: A case report
por: Morishita, Asahiro, et al.
Publicado: (2017)

Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs
por: Fujita, Koji, et al.
Publicado: (2016)

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Shi, Tingting, et al.
Publicado: (2021)

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C
por: Fujita, Koji, et al.
Publicado: (2019)

Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literature
por: Oura, Kyoko, et al.
Publicado: (2021)

Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
por: Fujita, Koji, et al.
Publicado: (2018)

Submucosal tunneling techniques: current perspectives
por: Kobara, Hideki, et al.
Publicado: (2014)

Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report
por: Sato, Yudai, et al.
Publicado: (2023)

Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three-dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion
por: Nomura, Takako, et al.
Publicado: (2019)

Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo
por: Shi, Tingting, et al.
Publicado: (2020)

Simple and reliable treatment for post-EMR artificial ulcer floor with snare cauterization for 10- to 20-mm colorectal polyps: a randomized prospective study (with video)
por: Mori, Hirohito, et al.
Publicado: (2014)

Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis
por: Fujita, Koji, et al.
Publicado: (2019)

Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
por: Tani, Joji, et al.
Publicado: (2021)

Nutritional Support for Alcoholic Liver Disease
por: Tadokoro, Tomoko, et al.
Publicado: (2023)

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study
por: Tani, Joji, et al.
Publicado: (2020)

Evaluation of gastric submucosal tumors using endoscopically visualized features with submucosal endoscopy
por: KOBARA, HIDEKI, et al.
Publicado: (2014)

Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

Effective and Secure Closure after Duodenal Endoscopic Submucosal Dissection: Combination of Endoscopic Ligation with O-Ring Closure and Over-the-Scope Clip
por: Nakatani, Kaho, et al.
Publicado: (2023)

MicroRNA Expression Profiles in Superficial Esophageal Squamous Cell Carcinoma before Endoscopic Submucosal Dissection: A Pilot Study
por: Fujihara, Shintaro, et al.
Publicado: (2021)

MicroRNA Interference in Hepatic Host-Pathogen Interactions
por: Morishita, Asahiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pjpcjqh7ut678rpse7uu38kmpb